首站-论文投稿智能助手
典型文献
Genomic landscape of T-cell lymphoblastic lymphoma
文献摘要:
Objective:T-cell lymphoblastic lymphoma(T-LBL)is an aggressive neoplasm of precursor T cells,however,detailed genome-wide sequencing of large T-LBL cohorts has not been performed due to its rarity.The purpose of this study was to identify putative driver genes in T-LBL.Methods:To gain insight into the genetic mechanisms of T-LBL development,we performed whole-exome sequencing on 41 paired tumor-normal DNA samples from patients with T-LBL.Results:We identified 32 putative driver genes using whole-exome sequencing in 41 T-LBL cases,many of which have not previously been described in T-LBL,such as Janus kinase 3(JAK3),Janus kinase 1(JAK1),Runt-related transcription factor 1(RUNX1)and Wilms'tumor suppressor gene 1(WT1).When comparing the genetic alterations of T-LBL to T-cell acute lymphoblastic leukemia(T-ALL),we found that JAK-STAT and RAS pathway mutations were predominantly observed in T-LBL(58.5%and 34.1%,respectively),whereas Notch and cell cycle signaling pathways mutations were more prevalent in T-ALL.Notably,besides notch receptor 1(NOTCH1),mutational status of plant homeodomain(PHD)-like finger protein 6(PHF6)was identified as another independent factor for good prognosis.Of utmost interest is that co-existence of PHF6 and NOTCH1 mutation status might provide an alternative for early therapeutic stratification in T-LBL.Conclusions:Together,our findings will not only provide new insights into the molecular and genetic mechanisms of T-LBL,but also have tangible implications for clinical practice.
文献关键词:
作者姓名:
Zhaoming Li;Yue Song;Mingzhi Zhang;Yiming Wei;Hang Ruan
作者机构:
Department of Oncology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;State Key Laboratory of Esophageal Cancer Prevention&Treatment and Henan Key Laboratory for Esophageal Cancer Research,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China
引用格式:
[1]Zhaoming Li;Yue Song;Mingzhi Zhang;Yiming Wei;Hang Ruan-.Genomic landscape of T-cell lymphoblastic lymphoma)[J].中国癌症研究(英文版),2022(02):83-94
A类:
B类:
Genomic,landscape,lymphoblastic,lymphoma,Objective,LBL,aggressive,neoplasm,precursor,cells,however,detailed,genome,wide,sequencing,large,cohorts,has,been,performed,due,its,rarity,purpose,this,study,was,identify,putative,driver,genes,Methods,gain,into,genetic,mechanisms,development,whole,exome,paired,tumor,normal,samples,from,patients,Results,We,identified,using,cases,many,which,have,previously,described,such,Janus,kinase,JAK3,JAK1,Runt,related,transcription,RUNX1,Wilms,suppressor,WT1,When,comparing,alterations,acute,leukemia,ALL,found,that,STAT,RAS,mutations,were,predominantly,observed,respectively,whereas,Notch,cycle,signaling,pathways,more,prevalent,Notably,besides,notch,receptor,NOTCH1,mutational,status,plant,homeodomain,PHD,like,finger,protein,PHF6,another,independent,good,prognosis,Of,utmost,interest,existence,might,provide,alternative,early,therapeutic,stratification,Conclusions,Together,our,findings,will,only,new,insights,molecular,but,also,tangible,implications,clinical,practice
AB值:
0.641168
相似文献
PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells
Wei Tang;Yu Wu;Xin Qi;Rilei Yu;Zhimin Lu;Ao Chen;Xinglong Fan;Jing Li-Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China;Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease of the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China;Department of Thoracic Surgery, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao 266003, China;Open Studio for Druggability Research of Marine Natural Products, Pilot National Laboratory for Marine Science and Technology (Qingdao), Qingdao 266003, China;Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao 266003, China
Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/ BRAF/TAK1/ERK/ETV4 signaling
Panpan Ma;Xinxin Jin;Zhiwei Fan;Zhou Wang;Suhui Yue;Changyue Wu;Shiyin Chen;Yuanyuan Wu;Miaomiao Chen;Donghua Gu;Siliang Zhang;Renfang Mao;Yihui Fan-Laboratory of Medical Science,School of Medicine,Nantong University,Nantong 226001,China;Department of Pathogenic Biology,School of Medicine,Nantong University,Nantong 226001,China;Department of Clinical Laboratory,Yancheng No.1 People's Hospital,Yancheng 224005,China;School of Life Sciences,Nantong University,Nantong 226001,China;Department of Dermatology,Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Urology,the Second Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Radiotherapy Oncology,Harbin Medical University Cancer Hospital,Harbin 150086,China;Department of Pathophysiology,School of Medicine,Nantong University,Nantong 226001,China
Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population
Jianfei Yao;Yunhuan Zhen;Jing Fan;Yuan Gong;Yumeng Ye;Shaohua Guo;Hongyi Liu;Xiaoyun Li;Guosheng Li;Pan Yang;Xiaohui Wang;Danni Liu;Tanxiao Huang;Huiya Cao;Peisu Suo;Yuemin Li;Jingbo Yu;Lele Song-Department of Radiotherapy,the Eighth Medical Center of the Chinese PLA General Hospital,Beijing 100091,China;HaploX Biotechnology,Shenzhen 518057,China;Department of Colorectal Surgery,Affiliated Hospital of Guizhou Medical University,Guiyang 550004,China;International Business School,Beijing Foreign Studies University,Beijing 100089,China;Department of Gastroenterology,the Second Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Experimental Pathology,Beijing Institute of Radiation Medicine,Beijing 100850,China;Department of General Surgery,the First Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Hepatobiliary Surgery,Dalian Municipal Central Hospital,Dalian Medical University,Dalian 116033,China;Comprehensive Liver Cancer Department,the Fifth Medical Center of the Chinese PLA General Hospital,Beijing 100039,China
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Yujiao Wang;Xi Jiao;Shuang Li;Huan Chen;Xin Wei;Chang Liu;Jifang Gong;Xiaotian Zhang;Xicheng Wang;Zhi Peng;Changsong Qi;Zhenghang Wang;Yanni Wang;Na Zhuo;Jianling Zou;Henghui Zhang;Jian Li;Lin Shen;Zhihao Lu-Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Gastric&Colorectal Surgery,The First Hospital of Jilin University,Changchun 130021,China;Genecast Precision Medicine Technology Institute,Beijing 100192,China;Life Sciences Institute,Zhejiang University,Hangzhou 310058,China;Institute of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China
Biallelic mutations in spermatogenesis and centrioie-associated 1 like(SPATC1L)cause acephalic spermatozoa syndrome and male infertility
You-Zhu Li;Na Li;Wen-Sheng Liu;Yan-Wei Sha;Rong-Feng Wu;Ya-Ling Tang;Xing-Shen Zhu;Xiao-Li Wei;Xiao-Ya Zhang;Yi-Feng Wang;Zhong-Xian Lu;Fu-Xing Zhang-Reproductive Medicine Center,The First Affiliated Hospital of Xiamen University,Xiamen 361003,China;Intensive Care Unit,Fujian Medical University Xiamen Humanity Hospital,Xiamen 361009,China;Obstetrics and Gynecology Center,Department of Obstetrics and Gynecology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;School of Pharmaceutical Sciences,State Key Laboratory of Cellular Stress Biology,Xiamen University,Xiamen 361102,China;Department of Andrology,United Diagnostic and Research Center for Clinical Genetics,Women and Children's Hospital and School of Medicine,Xiamen University,Xiamen 361005,China;Department of Obstetrics and Gynecology,First Affiliated Hospital of Xiamen University,Xiamen 361003,China;Department of General Surgery,First Affiliated Hospital of Xiamen University,Xiamen 361003,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。